Diagnosis of stomach cancer (also known as gastric cancer) is now occurring more often at earlier stages, likely related to advances in tests and imaging. Importantly, stomach cancer is also being ...

Gastric Cancer Diagnostics Market size was valued at US$ 3.5 Bn in 2024 and is projected to reach US$ 6.9 Bn by 2035, growing ...

Cancer usually grows quietly for years before it causes pain, bleeding or weight loss. By the time symptoms appear, disease ...

Blood tests that promise to spot cancer before symptoms appear are racing toward clinics, pitched as a simple vial of blood ...

As new technology capable of detecting dozens of early-stage cancer types with a single blood test hits the market, support for its use is building.

Stomach cancer is one of the most problematic cancers because, at its early stages, symptoms are either nonexistent or very vague and easy to dismiss, like heartburn, indigestion, and feeling full or ...

Stomach Cancer is known to be an illness most frequently seen in elderly people over 50 to 70 years of age. However, these ...

The HER2-positive gastric cancer market is set for sustained growth, driven by rising global disease prevalence and expanded HER2 testing that increases the number of patients eligible for targeted ...

Esophagus cancer and stomach cancer affect different parts of the gastrointestinal (GI) tract. However, some types of cancer start where the esophagus and stomach meet. The esophagus is the tube that ...